Username Password
S&P 500: 1,351.68 Change: +0.14%

DURECT CP (DRRX)

Overview
Price 0.82
Price Change Today -$0.03 (-3.53%)
P&P rating Rating: 5
Zacks Rank N/A - N/A
Open Price $0.85
Previous Close $0.85
Daily Range $0.82 - $0.85
52-Week Range $0.72 - $3.77
Volume 198,024
chart
Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.
Other Resources for DRRX
zacks.com
Commentary
Zacks Blog: CRL for Pfizer/Pain's Remoxy
June 27, 2011
Zacks Blog: FDA Approves Pfizer/Acura's Oxecta
June 23, 2011
Zacks Blog: Encouraging Data on Remoxy
April 26, 2011
Zacks Blog: Boost for Hospira
March 11, 2011
Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.
 
Brokerage Analyst Recommendations
1 Brokerage Firms Covering DRRX
 
 
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1
 
DRRX Ratings:BUY  SELL  HOLD
DRRX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

14 Buy
0 Sell
 
Top Buy Analysis
BUY: DRRX Rating: 5
Company: DURECT CORPORATION
Points: -78.16
Start Price: $3.05
Start Date: 01/29/2011 9:10 AM
dwarf
dwarf
P&P Score: 99.56
Recs:
headed to 200 dma

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 06/27/11 CRL for Pfizer/Pain's Remoxy - Analyst Blog 0
Zacks_Analysts
0.00 06/23/11 FDA Approves Pfizer/Acura's Oxecta - Analyst Blog 0
Zacks_Analysts
0.00 04/26/11 Encouraging Data on Remoxy - Analyst Blog 0
Zacks_Analysts
0.00 03/11/11 Boost for Hospira - Analyst Blog 0
Zacks_Analysts
0.00 02/02/11 Hospira Misses; 2011 View Weak - Analyst Blog 0
Zacks_Analysts
0.00 01/24/11 Pfizer Extends King Tender Offer - Analyst Blog 0
Zacks_Analysts
0.00 12/29/10 King Pharma Resubmits Remoxy NDA - Analyst Blog 0
Zacks_Analysts
0.00 07/28/10 Hospira Tops on EPS, Misses on Revs - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Earnings Preview: Hospira - Analyst Blog 0
Zacks_Analysts
0.00 06/25/10 FDA Clears Hospira's Generic Drug - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $3.05
Points: -78.16
Created: 01/29/2011
headed to 200 dma

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $3.61
Points: -81.08
Created: 01/16/2011
volume breakout, + 4 weeks tight in chart

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $4.70
Points: -89.47
Created: 07/25/2008
the company makes drugs, its drug delivery technology platforms and they have a good pipe line of new drugs coming thats is at late stages. tha stock trades at a L -$3.00 -H -$ 7.00.I think it trades $ 9.00-$15.00.

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $4.93
Points: -88.26
Created: 07/23/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $5.25
Points: -75.96
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $6.35
Points: -78.75
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $4.85
Points: -74.63
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $3.54
Points: -68.18
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $6.70
Points: -79.45
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: DURECT CORPORATION (DRRX) Rating: 5
Start Price: $6.17
Points: -78.37
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
dwarf 99.56 BUY Week or Less 01/29/2011 $3.05 $0.85
(-0.51%)
-72.26% +5.90% -78.16 view
frankbean 1.96 BUY Six Months to a Year 01/16/2011 $3.61 $0.85
(-0.51%)
-76.56% +4.52% -81.08 view
laz171 BUY One to Three Years 07/25/2008 $4.70 $0.85
(-0.51%)
-82.00% +7.47% -89.47 view
Boone 78.44 BUY Week to a Month 07/23/2008 $4.93 $0.85
(-0.51%)
-82.84% +5.42% -88.26
cj14 92.04 BUY Six Months to a Year 01/01/2008 $5.25 $0.85
(-0.51%)
-83.88% -7.92% -75.96
caddiemaster 22.54 BUY Six Months to a Year 01/01/2008 $6.35 $0.85
(-0.51%)
-86.68% -7.92% -78.75
chriso61 83.02 BUY Six Months to a Year 01/01/2008 $4.85 $0.85
(-0.51%)
-82.55% -7.92% -74.63
belluhs 92.04 BUY Six Months to a Year 01/01/2008 $3.54 $0.85
(-0.51%)
-76.10% -7.92% -68.18
miajunior 74.48 BUY Six Months to a Year 01/01/2008 $6.70 $0.85
(-0.51%)
-87.37% -7.92% -79.45
commoncents 27.37 BUY Six Months to a Year 01/01/2008 $6.17 $0.85
(-0.51%)
-86.29% -7.92% -78.37
Pages: [ 1 ]  2  >>
Sponsored Links